Heart drugs take on warts: new injection shows promise
NCT ID NCT07307131
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested two different injections for treating skin warts caused by HPV. One group received a mix of furosemide and digoxin (drugs usually used for heart conditions), while the other got polidocanol, a standard treatment. Researchers tracked how well each cleared the warts and checked for side effects and return of warts over 6 months. The trial involved 64 adults with single or multiple warts.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
furosemide and digoxin injection
What this could lead to
If this works, it could offer a new, effective injection treatment for common warts that is safe and has low recurrence.
What could go wrong
This is a small, early-phase trial with only 64 people. The combination drug may cause side effects like pain or swelling, and results may not apply to everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS (HPV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
faculty of Medicine
Banhā, Qalyubia Governorate, 13518, Egypt